Impact of rheumatoid arthritis treatment on arterial stiffness

被引：0

作者：

Dragoi, R. G. ^{[1
]}

Avram, C.

Dragoi, M. ^{[1
]}

Popoviciu, H.

Nagel, A.

Duer, M.

Milicin, C. ^{[1
]}

Stamm, T. A.

机构：

[1] Victor Babes Univ Med & Pharm, Timisoara, Romania

来源：

PROCEEDINGS OF THE 7TH WORLD CONGRESS OF INTERNATIONAL SOCIETY OF PHYSICAL AND REHABILITATION MEDICINE | 2013年

关键词：

CARDIOVASCULAR-DISEASE; RISK-FACTORS;

D O I：

暂无

中图分类号：

R49 [康复医学];

学科分类号：

100215 ;

摘要：

引用

页码：247 / 249

页数：3

共 11 条

[1] Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies [J].

Avina-Zubieta, J. Antonio ;

Choi, Hyon K. ;

Sadatsafavi, Mohsen ;

Etminan, Mahyar ;

Esdaile, John M. ;

Lacaille, Diane .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12) :1690-1697

[2] Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis [J].

Haagsma, CJ ;

Blom, HJ ;

van Riel, PLCM ;

van't Hof, MA ;

Giesendorf, BAJ ;

van Oppenraaij-Emmerzaal, D ;

van de Putte, LBA .

ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (02) :79-84

[3]

Han CL, 2006, J RHEUMATOL, V33, P2167

[4] Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis - A population-based cohort study [J].

Maradit-Kremers, H ;

Crowson, CS ;

Nicola, PJ ;

Ballman, KV ;

Roger, VL ;

Jacobsen, SJ ;

Gabriel, SE .

ARTHRITIS AND RHEUMATISM, 2005, 52 (02) :402-411

[5] EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis [J].

Peters, M. J. L. ;

Symmons, D. P. M. ;

McCarey, D. ;

Dijkmans, B. A. C. ;

Nicola, P. ;

Kvien, T. K. ;

McInnes, I. B. ;

Haentzschel, H. ;

Gonzalez-Gay, M. A. ;

Provan, S. ;

Semb, A. ;

Sidiropoulos, P. ;

Kitas, G. ;

Smulders, Y. M. ;

Soubrier, M. ;

Szekanecz, Z. ;

Sattar, N. ;

Nurmohamed, M. T. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) :325-331

[6] Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis [J].

Popa, C ;

Netea, MG ;

Radstake, T ;

Van der Meer, JWM ;

Stalenhoef, AFH ;

van Riel, PLCM ;

Barerra, P .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :303-305

[7] Arterial stiffness in chronic inflammatory diseases [J].

Roman, MJ ;

Devereux, RB ;

Schwartz, JE ;

Lockshin, MD ;

Paget, SA ;

Davis, A ;

Crow, MK ;

Sammaritano, L ;

Levine, DM ;

Shankar, BA ;

Moeller, E ;

Salmon, JE .

HYPERTENSION, 2005, 46 (01) :194-199

[8] Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study [J].

Turesson, C ;

Jarenros, A ;

Jacobsson, L .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (08) :952-955

[9] Accelerated atherosclerosis - An extraarticular feature of rheumatoid arthritis? [J].

Van Doornum, S ;

McColl, G ;

Wicks, IP .

ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :862-873

[10] Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study [J].

van Halm, Vokko P. ;

Nurmohamed, Michael T. ;

Twisk, Jos W. R. ;

Dijkmans, Ben A. C. ;

Voskuyl, Alexandre E. .

ARTHRITIS RESEARCH & THERAPY, 2006, 8 (05)

← 1 2 →